MAP3K2 and cancer: Nonetheless, our findings portend that other Ras-dependent cancers with increased abundance of SMYD3 are also likely to maintain a feedback loop driving high SMYD levels dependent on persistent activation of MAP3K2/MEK/ERK signaling.